1991
DOI: 10.1021/bi00243a013
|View full text |Cite
|
Sign up to set email alerts
|

Identification of cysteine-319 as the target amino acid of 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5'-triphosphate in bovine liver glutamate dehydrogenase

Abstract: The affinity label 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5'-triphosphate (8-BDB-TA-5'-TP) has been shown to react with bovine liver glutamate dehydrogenase in the region of the GTP-dependent NADH inhibitory site with incorporation of about 1 mol of reagent/mol of subunit [Ozturk, D. H., Safer, D., & Colman, R. F. (1990) Biochemistry 29, 7112-7118]. The modified enzyme was shown to contain only 5 free sulfhydryl groups upon 5,5'-dithiobis (2-nitrobenzoate) titration as compared with 6 in the unmodified enzy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
16
0

Year Published

1991
1991
2005
2005

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 44 publications
1
16
0
Order By: Relevance
“…Similar results with discrepancy using classical chemical probes were also reported by the same research group to identify other regulatory sites within bovine liver GDH. The NADH binding site was proposed to be modified by an ATP analogue at Cys 319 (9), by a GMP probe at Met 169 and Tyr 262 (10), and by the adenosine analogue at Lys 420 and Tyr 190 (11). The GTP binding site was also proposed to be modified by 5Ј-p-(fluorosulfonyl)benzoyl-1,N 6 -ethenoadenosine at Tyr 262 (24).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Similar results with discrepancy using classical chemical probes were also reported by the same research group to identify other regulatory sites within bovine liver GDH. The NADH binding site was proposed to be modified by an ATP analogue at Cys 319 (9), by a GMP probe at Met 169 and Tyr 262 (10), and by the adenosine analogue at Lys 420 and Tyr 190 (11). The GTP binding site was also proposed to be modified by 5Ј-p-(fluorosulfonyl)benzoyl-1,N 6 -ethenoadenosine at Tyr 262 (24).…”
Section: Discussionmentioning
confidence: 99%
“…This is especially likely if they display low affinity for the binding site being studies. Their lack of specificity may be the reason for the wide three-dimensional distribution of the residues identified using classical chemical probes as being in the NADH inhibitory site of GDH (9,10). An analysis of the three-dimensional structure of the mammalian enzyme should supplement the understanding of the nature and location of these regulatory sites.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is especially likely if they display low affinity for the binding site being studied. Their lack of specificity may be the reason for the wide three-dimensional distribution of the residues identified using classical chemical probes as being in the NADH inhibitory site of GDH (8,9). Very recently, Stanley et al (38) have reported that the hyperinsulinism-hyperammonemia syndrome is caused by mutations in GDH gene that affect enzyme sensitivity to GTPinduced inhibition.…”
Section: Nad ϩ Binding Site Of Brain Gdh Isoproteinsmentioning
confidence: 99%
“…The studies using classical chemical probes to identify the NADH and GTP binding sites within bovine liver GDH, however, gave a wide scatter of modified residues throughout most of the proposed threedimensional structure of GDH. For instance, the NADH binding site was proposed to be modified by an ATP analogue at Cys 319 (8), by a GMP probe at Met 169 and Tyr 262 (9), and by the adenosine analogue at Lys 420 and Tyr 190 (10). It seems, therefore, that the base moiety has not been effective at directing the site of modification by classical chemical probes.…”
mentioning
confidence: 99%